Dora Ling
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Cancer-related molecular mechanisms research
Papers in
-
- Histone Deacetylase Inhibitors Research 2
- Signaling Pathways in Disease 1
- Protein Degradation and Inhibitors 1
-
- Neuroblastoma Research and Treatments 3
- Co-authors
- Tao Liu (5 shared papers)Pei Y. Liu (4 shared papers)Glenn M. Marshall (3 shared papers)Michelle Haber (2 shared papers)Ning Xu (2 shared papers)Murray D. Norris (2 shared papers)Bernard Atmadibrata (3 shared papers)Andrew E. Tee (3 shared papers)
- Journals
- PLoS Genetics (1 paper)Oncotarget (1 paper)European Journal of Cancer (1 paper)Biological Research (1 paper)Molecular Therapy — Methods & Clinical Development (1 paper)
- Partner nations
- AustraliaUnited StatesItaly
In The Last Decade
Dora Ling
8 papers receiving 353 citations
Peers
Comparison fields: 5 of 52
- Geriatrics and Gerontology 59
- Cancer Research 123
- Physiology 22
- Neurology 60
- Molecular Biology 266
Countries citing papers authored by Dora Ling
This map shows the geographic impact of Dora Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Ling more than expected).
Fields of papers citing papers by Dora Ling
This network shows the impact of papers produced by Dora Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Ling. The network helps show where Dora Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Dora Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 122 | |
| 2 | 2014 | 97 | |
| 3 | 2017 | 53 | |
| 4 | 2021 | 22 | |
| 5 | 2017 | 21 | |
| 6 | 2017 | 16 | |
| 7 | 2012 | 14 | |
| 8 | 2015 | 12 |
About Dora Ling
Dora Ling is a scholar working on Molecular Biology, Neurology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 357 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Neuroblastoma Research and Treatments (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Pancreatic function and diabetes (1 paper), Signaling Pathways in Disease (1 paper), Trace Elements in Health (1 paper), Protein Degradation and Inhibitors (1 paper) and Diabetes Management and Research (1 paper). The work is most often cited by research in Geriatrics and Gerontology (59 citations), Cancer Research (123 citations), Physiology (22 citations), Neurology (60 citations) and Molecular Biology (266 citations). Dora Ling has collaborated with scholars based in Australia, United States and Italy. Frequent co-authors include Tao Liu, Pei Y. Liu, Glenn M. Marshall, Michelle Haber, Ning Xu, Murray D. Norris, Bernard Atmadibrata, Andrew E. Tee, Christopher J. Scarlett and Giovanni Perini. Their work appears in journals such as PLoS Genetics, Oncotarget, European Journal of Cancer, Biological Research and Molecular Therapy — Methods & Clinical Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.